Angiogenesis PET Using Radiolabeled RGD Peptides View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

2010

AUTHORS

Keon Wook Kang , Jae Min Jeong , Ambros J. Beer

ABSTRACT

Angiogenesis, the process of developing a new vessel, is an essential feature of the growth of solid tumors. For decades, the targeting of tumor angiogenesis has evolved into one of the most widely pursued therapeutic strategies in cancer research. Antiangiogenic drugs like bevaci-zumab, sunitinib, or sorafenib, were proved to be effective in many solid cancers such as colorectal cancer, renal cell carcinoma, hepatocelluar carcinoma, etc. But, these kinds of molecular targeted therapy are responsive only in selected patient population. More... »

PAGES

195-211

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-3-540-93909-2_12

DOI

http://dx.doi.org/10.1007/978-3-540-93909-2_12

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1010718679


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.31501.36", 
          "name": [
            "Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kang", 
        "givenName": "Keon Wook", 
        "id": "sg:person.0761746266.86", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0761746266.86"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.31501.36", 
          "name": [
            "Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jeong", 
        "givenName": "Jae Min", 
        "id": "sg:person.01301360400.94", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01301360400.94"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Nuclearmedizinische Klinik, Technische Universit\u00e4t M\u00fcnchen, M\u00fcnchen, Germany", 
          "id": "http://www.grid.ac/institutes/grid.6936.a", 
          "name": [
            "Nuclearmedizinische Klinik, Technische Universit\u00e4t M\u00fcnchen, M\u00fcnchen, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Beer", 
        "givenName": "Ambros J.", 
        "id": "sg:person.0702550110.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0702550110.49"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2010", 
    "datePublishedReg": "2010-01-01", 
    "description": "Angiogenesis, the process of developing a new vessel, is an essential feature of the growth of solid tumors. For decades, the targeting of tumor angiogenesis has evolved into one of the most widely pursued therapeutic strategies in cancer research. Antiangiogenic drugs like bevaci-zumab, sunitinib, or sorafenib, were proved to be effective in many solid cancers such as colorectal cancer, renal cell carcinoma, hepatocelluar carcinoma, etc. But, these kinds of molecular targeted therapy are responsive only in selected patient population.", 
    "editor": [
      {
        "familyName": "Fanti", 
        "givenName": "Stefano", 
        "type": "Person"
      }, 
      {
        "familyName": "Farsad", 
        "givenName": "Mohsen", 
        "type": "Person"
      }, 
      {
        "familyName": "Mansi", 
        "givenName": "Luigi", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-3-540-93909-2_12", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-3-540-93908-5", 
        "978-3-540-93909-2"
      ], 
      "name": "PET-CT Beyond FDG A Quick Guide to Image Interpretation", 
      "type": "Book"
    }, 
    "keywords": [
      "renal cell carcinoma", 
      "colorectal cancer", 
      "cell carcinoma", 
      "patient population", 
      "antiangiogenic drugs", 
      "hepatocelluar carcinoma", 
      "solid cancers", 
      "therapeutic strategies", 
      "solid tumors", 
      "tumor angiogenesis", 
      "new vessels", 
      "carcinoma", 
      "cancer", 
      "cancer research", 
      "angiogenesis", 
      "sunitinib", 
      "sorafenib", 
      "therapy", 
      "tumors", 
      "RGD peptide", 
      "drugs", 
      "vessels", 
      "PET", 
      "targeting", 
      "population", 
      "peptides", 
      "strategies", 
      "decades", 
      "features", 
      "growth", 
      "research", 
      "essential features", 
      "process", 
      "kind"
    ], 
    "name": "Angiogenesis PET Using Radiolabeled RGD Peptides", 
    "pagination": "195-211", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1010718679"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-3-540-93909-2_12"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-3-540-93909-2_12", 
      "https://app.dimensions.ai/details/publication/pub.1010718679"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2022-11-24T21:14", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/chapter/chapter_268.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-3-540-93909-2_12"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-3-540-93909-2_12'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-3-540-93909-2_12'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-3-540-93909-2_12'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-3-540-93909-2_12'


 

This table displays all metadata directly associated to this object as RDF triples.

120 TRIPLES      22 PREDICATES      59 URIs      52 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-3-540-93909-2_12 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author Ncdd53719af5540e7a8366b83f0712c4a
4 schema:datePublished 2010
5 schema:datePublishedReg 2010-01-01
6 schema:description Angiogenesis, the process of developing a new vessel, is an essential feature of the growth of solid tumors. For decades, the targeting of tumor angiogenesis has evolved into one of the most widely pursued therapeutic strategies in cancer research. Antiangiogenic drugs like bevaci-zumab, sunitinib, or sorafenib, were proved to be effective in many solid cancers such as colorectal cancer, renal cell carcinoma, hepatocelluar carcinoma, etc. But, these kinds of molecular targeted therapy are responsive only in selected patient population.
7 schema:editor N493206ee8ec34d9d86d85b5a5f75bff0
8 schema:genre chapter
9 schema:isAccessibleForFree false
10 schema:isPartOf N81a33735443a4662901d9d5a023fe288
11 schema:keywords PET
12 RGD peptide
13 angiogenesis
14 antiangiogenic drugs
15 cancer
16 cancer research
17 carcinoma
18 cell carcinoma
19 colorectal cancer
20 decades
21 drugs
22 essential features
23 features
24 growth
25 hepatocelluar carcinoma
26 kind
27 new vessels
28 patient population
29 peptides
30 population
31 process
32 renal cell carcinoma
33 research
34 solid cancers
35 solid tumors
36 sorafenib
37 strategies
38 sunitinib
39 targeting
40 therapeutic strategies
41 therapy
42 tumor angiogenesis
43 tumors
44 vessels
45 schema:name Angiogenesis PET Using Radiolabeled RGD Peptides
46 schema:pagination 195-211
47 schema:productId N0b01dec105114dc78489ecc86dc250f8
48 Nc6faced510dc4e539c5ca1d5f08ec1e2
49 schema:publisher Nad3cb5f9a58b4edd9f3371e9525d7e25
50 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010718679
51 https://doi.org/10.1007/978-3-540-93909-2_12
52 schema:sdDatePublished 2022-11-24T21:14
53 schema:sdLicense https://scigraph.springernature.com/explorer/license/
54 schema:sdPublisher Ncb00f9151de1422f9701bf7b761b5c2f
55 schema:url https://doi.org/10.1007/978-3-540-93909-2_12
56 sgo:license sg:explorer/license/
57 sgo:sdDataset chapters
58 rdf:type schema:Chapter
59 N0b01dec105114dc78489ecc86dc250f8 schema:name doi
60 schema:value 10.1007/978-3-540-93909-2_12
61 rdf:type schema:PropertyValue
62 N18e45c59774a49598d6ae384d973743e schema:familyName Fanti
63 schema:givenName Stefano
64 rdf:type schema:Person
65 N289cfee02c9449a3ae20156b4229c388 rdf:first sg:person.0702550110.49
66 rdf:rest rdf:nil
67 N44f54d1207b94aa3a0c06ecfd840b3c7 rdf:first N5ebe9245e9eb49509ca0e801d9c65708
68 rdf:rest rdf:nil
69 N493206ee8ec34d9d86d85b5a5f75bff0 rdf:first N18e45c59774a49598d6ae384d973743e
70 rdf:rest Nc6a3177540de42a096d6753fce23ecb1
71 N5ebe9245e9eb49509ca0e801d9c65708 schema:familyName Mansi
72 schema:givenName Luigi
73 rdf:type schema:Person
74 N7aa045f878584a339f53e530906cf654 rdf:first sg:person.01301360400.94
75 rdf:rest N289cfee02c9449a3ae20156b4229c388
76 N81a33735443a4662901d9d5a023fe288 schema:isbn 978-3-540-93908-5
77 978-3-540-93909-2
78 schema:name PET-CT Beyond FDG A Quick Guide to Image Interpretation
79 rdf:type schema:Book
80 Nad3cb5f9a58b4edd9f3371e9525d7e25 schema:name Springer Nature
81 rdf:type schema:Organisation
82 Nbab495c63a2c4457924a422118ff7341 schema:familyName Farsad
83 schema:givenName Mohsen
84 rdf:type schema:Person
85 Nc6a3177540de42a096d6753fce23ecb1 rdf:first Nbab495c63a2c4457924a422118ff7341
86 rdf:rest N44f54d1207b94aa3a0c06ecfd840b3c7
87 Nc6faced510dc4e539c5ca1d5f08ec1e2 schema:name dimensions_id
88 schema:value pub.1010718679
89 rdf:type schema:PropertyValue
90 Ncb00f9151de1422f9701bf7b761b5c2f schema:name Springer Nature - SN SciGraph project
91 rdf:type schema:Organization
92 Ncdd53719af5540e7a8366b83f0712c4a rdf:first sg:person.0761746266.86
93 rdf:rest N7aa045f878584a339f53e530906cf654
94 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
95 schema:name Medical and Health Sciences
96 rdf:type schema:DefinedTerm
97 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
98 schema:name Oncology and Carcinogenesis
99 rdf:type schema:DefinedTerm
100 sg:person.01301360400.94 schema:affiliation grid-institutes:grid.31501.36
101 schema:familyName Jeong
102 schema:givenName Jae Min
103 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01301360400.94
104 rdf:type schema:Person
105 sg:person.0702550110.49 schema:affiliation grid-institutes:grid.6936.a
106 schema:familyName Beer
107 schema:givenName Ambros J.
108 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0702550110.49
109 rdf:type schema:Person
110 sg:person.0761746266.86 schema:affiliation grid-institutes:grid.31501.36
111 schema:familyName Kang
112 schema:givenName Keon Wook
113 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0761746266.86
114 rdf:type schema:Person
115 grid-institutes:grid.31501.36 schema:alternateName Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea
116 schema:name Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea
117 rdf:type schema:Organization
118 grid-institutes:grid.6936.a schema:alternateName Nuclearmedizinische Klinik, Technische Universität München, München, Germany
119 schema:name Nuclearmedizinische Klinik, Technische Universität München, München, Germany
120 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...